Annual EBIT
-$13.92 M
+$1.35 M+8.82%
31 December 2023
Summary:
Predictive Oncology annual earnings before interest & taxes is currently -$13.92 million, with the most recent change of +$1.35 million (+8.82%) on 31 December 2023. During the last 3 years, it has fallen by -$449.70 thousand (-3.34%). POAI annual EBIT is now -1054.72% below its all-time high of -$1.20 million.POAI EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$2.31 M
+$875.20 K+27.44%
30 September 2024
Summary:
Predictive Oncology quarterly earnings before interest & taxes is currently -$2.31 million, with the most recent change of +$875.20 thousand (+27.44%) on 30 September 2024. Over the past year, it has increased by +$2.51 million (+52.05%). POAI quarterly EBIT is now -446.25% below its all-time high of $668.30 thousand, reached on 31 December 2010.POAI Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$14.57 M
+$425.00 K+2.83%
30 September 2024
Summary:
Predictive Oncology TTM earnings before interest & taxes is currently -$14.57 million, with the most recent change of +$425.00 thousand (+2.83%) on 30 September 2024. Over the past year, it has increased by +$260.30 thousand (+1.76%). POAI TTM EBIT is now -3185.14% below its all-time high of -$443.40 thousand, reached on 30 September 2008.POAI TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
POAI EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +52.0% | +1.8% |
| 3 y3 years | -3.3% | +47.6% | -8.1% |
| 5 y5 years | -1.1% | +20.0% | -5.8% |
POAI EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -3.3% | +8.8% | at high | +52.0% | -11.1% | +7.9% |
| 5 y | 5 years | -11.5% | +8.8% | at high | +52.0% | -25.0% | +7.9% |
| alltime | all time | -1054.7% | +8.8% | -446.3% | +54.6% | -3185.1% | +7.9% |
Predictive Oncology EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.31 M(-27.4%) | -$14.57 M(-2.8%) |
| June 2024 | - | -$3.19 M(-24.7%) | -$14.99 M(-3.9%) |
| Mar 2024 | - | -$4.24 M(-12.2%) | -$15.60 M(+5.2%) |
| Dec 2023 | -$13.92 M(-8.8%) | -$4.83 M(+76.2%) | -$14.83 M(+2.8%) |
| Sept 2023 | - | -$2.74 M(-27.9%) | -$14.43 M(-8.8%) |
| June 2023 | - | -$3.80 M(+9.6%) | -$15.82 M(+3.3%) |
| Mar 2023 | - | -$3.46 M(-21.8%) | -$15.32 M(+0.3%) |
| Dec 2022 | -$15.27 M(+13.3%) | -$4.43 M(+7.2%) | -$15.27 M(+0.1%) |
| Sept 2022 | - | -$4.13 M(+25.4%) | -$15.26 M(+10.5%) |
| June 2022 | - | -$3.29 M(-3.5%) | -$13.80 M(+5.3%) |
| Mar 2022 | - | -$3.41 M(-22.7%) | -$13.11 M(-2.7%) |
| Dec 2021 | -$13.47 M(+7.9%) | -$4.42 M(+64.8%) | -$13.47 M(+14.9%) |
| Sept 2021 | - | -$2.68 M(+3.1%) | -$11.72 M(+0.6%) |
| June 2021 | - | -$2.60 M(-31.2%) | -$11.65 M(-9.1%) |
| Mar 2021 | - | -$3.78 M(+41.8%) | -$12.82 M(+2.7%) |
| Dec 2020 | -$12.48 M(-9.4%) | -$2.66 M(+2.0%) | -$12.48 M(-1.8%) |
| Sept 2020 | - | -$2.61 M(-30.7%) | -$12.71 M(-6.2%) |
| June 2020 | - | -$3.77 M(+9.6%) | -$13.55 M(-8.9%) |
| Mar 2020 | - | -$3.44 M(+18.9%) | -$14.88 M(+8.0%) |
| Dec 2019 | -$13.77 M(+75.2%) | -$2.89 M(-16.0%) | -$13.77 M(+0.5%) |
| Sept 2019 | - | -$3.44 M(-32.4%) | -$13.71 M(+13.1%) |
| June 2019 | - | -$5.10 M(+118.2%) | -$12.12 M(+43.7%) |
| Mar 2019 | - | -$2.34 M(-17.3%) | -$8.44 M(+7.0%) |
| Dec 2018 | -$7.86 M(+29.9%) | -$2.83 M(+51.9%) | -$7.89 M(+26.5%) |
| Sept 2018 | - | -$1.86 M(+31.7%) | -$6.24 M(+16.2%) |
| June 2018 | - | -$1.41 M(-20.9%) | -$5.37 M(-17.4%) |
| Mar 2018 | - | -$1.79 M(+51.9%) | -$6.50 M(+7.3%) |
| Dec 2017 | -$6.05 M(-7.2%) | -$1.18 M(+18.5%) | -$6.05 M(+7.9%) |
| Sept 2017 | - | -$992.10 K(-61.0%) | -$5.61 M(-1.1%) |
| June 2017 | - | -$2.54 M(+89.6%) | -$5.67 M(-0.3%) |
| Mar 2017 | - | -$1.34 M(+83.1%) | -$5.69 M(-12.8%) |
| Dec 2016 | -$6.53 M | -$732.80 K(-30.6%) | -$6.53 M(-19.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | -$1.06 M(-58.8%) | -$8.06 M(-0.1%) |
| June 2016 | - | -$2.56 M(+17.7%) | -$8.07 M(+24.1%) |
| Mar 2016 | - | -$2.18 M(-4.0%) | -$6.50 M(+47.8%) |
| Dec 2015 | -$4.40 M(-31.9%) | -$2.27 M(+112.9%) | -$4.40 M(+2.7%) |
| Sept 2015 | - | -$1.06 M(+6.9%) | -$4.29 M(+1.9%) |
| June 2015 | - | -$996.10 K(+1279.6%) | -$4.20 M(-14.7%) |
| Mar 2015 | - | -$72.20 K(-96.6%) | -$4.93 M(-23.6%) |
| Dec 2014 | -$6.46 M(-26.4%) | -$2.15 M(+118.9%) | -$6.46 M(+0.1%) |
| Sept 2014 | - | -$983.30 K(-42.9%) | -$6.45 M(-28.6%) |
| June 2014 | - | -$1.72 M(+7.6%) | -$9.04 M(+8.0%) |
| Mar 2014 | - | -$1.60 M(-25.5%) | -$8.36 M(-4.6%) |
| Dec 2013 | -$8.77 M(+22.4%) | -$2.15 M(-39.8%) | -$8.77 M(+6.3%) |
| Sept 2013 | - | -$3.57 M(+240.1%) | -$8.25 M(+9.8%) |
| June 2013 | - | -$1.05 M(-47.7%) | -$7.51 M(-11.7%) |
| Mar 2013 | - | -$2.01 M(+23.3%) | -$8.51 M(+18.8%) |
| Dec 2012 | -$7.16 M(+68.3%) | -$1.63 M(-42.6%) | -$7.16 M(-15.2%) |
| Sept 2012 | - | -$2.83 M(+38.4%) | -$8.45 M(+36.0%) |
| June 2012 | - | -$2.05 M(+211.1%) | -$6.21 M(+38.2%) |
| Mar 2012 | - | -$657.90 K(-77.4%) | -$4.49 M(+5.5%) |
| Dec 2011 | -$4.26 M(+253.1%) | -$2.91 M(+391.3%) | -$4.26 M(+527.3%) |
| Sept 2011 | - | -$593.10 K(+79.6%) | -$679.30 K(+21.5%) |
| June 2011 | - | -$330.20 K(-22.2%) | -$559.30 K(-28.3%) |
| Mar 2011 | - | -$424.30 K(-163.5%) | -$780.10 K(-35.3%) |
| Dec 2010 | -$1.21 M(-57.1%) | $668.30 K(-241.3%) | -$1.21 M(-53.7%) |
| Sept 2010 | - | -$473.10 K(-14.1%) | -$2.61 M(-11.6%) |
| June 2010 | - | -$551.00 K(-35.2%) | -$2.95 M(-7.0%) |
| Mar 2010 | - | -$849.80 K(+16.0%) | -$3.17 M(+12.6%) |
| Dec 2009 | -$2.81 M(+68.1%) | -$732.30 K(-10.1%) | -$2.81 M(+0.1%) |
| Sept 2009 | - | -$814.30 K(+5.4%) | -$2.81 M(+15.2%) |
| June 2009 | - | -$772.60 K(+56.4%) | -$2.44 M(+46.4%) |
| Mar 2009 | - | -$494.10 K(-32.2%) | -$1.67 M(+42.1%) |
| Dec 2008 | -$1.67 M | -$729.10 K(+64.4%) | -$1.17 M(+164.4%) |
| Sept 2008 | - | -$443.40 K | -$443.40 K |
FAQ
- What is Predictive Oncology annual earnings before interest & taxes?
- What is the all time high annual EBIT for Predictive Oncology?
- What is Predictive Oncology quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Predictive Oncology?
- What is Predictive Oncology quarterly EBIT year-on-year change?
- What is Predictive Oncology TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Predictive Oncology?
- What is Predictive Oncology TTM EBIT year-on-year change?
What is Predictive Oncology annual earnings before interest & taxes?
The current annual EBIT of POAI is -$13.92 M
What is the all time high annual EBIT for Predictive Oncology?
Predictive Oncology all-time high annual earnings before interest & taxes is -$1.20 M
What is Predictive Oncology quarterly earnings before interest & taxes?
The current quarterly EBIT of POAI is -$2.31 M
What is the all time high quarterly EBIT for Predictive Oncology?
Predictive Oncology all-time high quarterly earnings before interest & taxes is $668.30 K
What is Predictive Oncology quarterly EBIT year-on-year change?
Over the past year, POAI quarterly earnings before interest & taxes has changed by +$2.51 M (+52.05%)
What is Predictive Oncology TTM earnings before interest & taxes?
The current TTM EBIT of POAI is -$14.57 M
What is the all time high TTM EBIT for Predictive Oncology?
Predictive Oncology all-time high TTM earnings before interest & taxes is -$443.40 K
What is Predictive Oncology TTM EBIT year-on-year change?
Over the past year, POAI TTM earnings before interest & taxes has changed by +$260.30 K (+1.76%)